Morgan Stanley Stock News

Morgan Stanley: Here''s Why We See No Rate Hikes In 2022 And What That Means For Markets By Vishwanath Tirupattur, global head of Quantitative Research at Morgan Stanley This has been our outlook week. We published our year-ahead global economics and strategy outlooks last Sunday, and more detailed asset class and country-specific outlooks have been streaming out during the week. At Morgan Stanley Research, our outlooks are the culmination of weeks of deliberation and spirited debate among economists and strategists across all the regions and asset classes we cover. In our highly inter-related world, where everything effectively affects everything else, I am convinced that such a collaborative exercise is necessary. In last weeks Start, my colleague Andrew Sheets summarized the outcome of the process our outlook for 2022 across markets and economies. This week, I will focus on the key debates we engaged in during the process. Our economists view that the Fed will wait until 1Q23 to make its first interest rate hike, despite their projection that US unemployment will fall to 3.6% by end-2022, was hotly debated.

Evercore ISI restated their buy rating on shares of Applied Materials (NASDAQ:AMAT) in a research report report published on Friday morning, TipRanks reports. The firm currently has a $185.00 price objective on the manufacturing equipment providers stock. A number of other equities analysts have also weighed in on AMAT. Morgan Stanley upped their target price []

McElhenny Sheffield Capital Management LLC purchased a new position in shares of Morgan Stanley (NYSE:MS) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,100 shares of the financial services providers stock, valued at approximately $1,275,000. Morgan Stanley comprises []

Naspers Limited (OTCMKTS:NPSNY) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $34.04 and traded as high as $34.58. Naspers shares last traded at $34.20, with a volume of 66,699 shares changing hands. Several research firms have recently commented on NPSNY. Morgan Stanley []

Morgan Stanley lessened its stake in Lithia Motors, Inc. (NYSE:LAD) by 26.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 49,911 shares of the companys stock after selling 17,758 shares during the period. Morgan Stanley owned 0.16% of Lithia Motors worth $17,152,000 as []

Marshall Wace North America L.P. acquired a new position in shares of Alkuri Global Acquisition Corp. (NASDAQ:KURI) in the 2nd quarter, HoldingsChannel reports. The institutional investor acquired 158,636 shares of the companys stock, valued at approximately $1,570,000. Several other large investors have also recently made changes to their positions in the stock. Morgan Stanley purchased []

Morgan Stanley will spearhead a six bank syndicate tasked with funding private equity group EQTs $2.3 billion acquisition of cancer services provider Icon Group.

Morgan Stanley boosted its holdings in shares of Rogers Co. (NYSE:ROG) by 22.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 82,272 shares of the electronics makers stock after buying an additional 15,299 shares during the period. Morgan Stanleys holdings in Rogers were worth []

Morgan Stanley lifted its stake in Revolution Medicines, Inc. (NASDAQ:RVMD) by 230.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 526,418 shares of the companys stock after purchasing an additional 367,073 shares during the period. Morgan Stanleys holdings in Revolution []

Morgan Stanley boosted its holdings in shares of iShares Currency Hedged MSCI EMU ETF (NYSEARCA:HEZU) by 3.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 454,770 shares of the companys stock after buying an additional 13,727 shares during the quarter. Morgan Stanley []

Morgan Stanley boosted its position in shares of Dynatrace, Inc. (NYSE:DT) by 86.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 289,785 shares of the companys stock after buying an additional 134,032 shares during the period. Morgan Stanley owned 0.10% of []

Morgan Stanley trimmed its position in First American Financial Co. (NYSE:FAF) by 29.2% during the second quarter, HoldingsChannel.com reports. The fund owned 269,805 shares of the insurance providers stock after selling 111,460 shares during the quarter. Morgan Stanleys holdings in First American Financial were worth $16,822,000 at the end of the most recent reporting period. []

Morgan Stanley increased its holdings in shares of Inari Medical, Inc. (NASDAQ:NARI) by 86.8% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 178,144 shares of the companys stock after purchasing an additional 82,802 shares during the period. Morgan Stanley owned approximately 0.36% of Inari Medical worth $16,617,000 []

ManTech International (NASDAQ:MANT) had its price objective trimmed by Morgan Stanley from $92.00 to $83.00 in a research note published on Wednesday morning, PriceTargets.com reports. The brokerage currently has an equal weight rating on the technology companys stock. Other analysts have also recently issued reports about the company. Bank of America cut ManTech International from []

BMO Capital Markets started coverage on shares of Pfizer (NYSE:PFE) in a report published on Thursday, Analyst Ratings Network reports. The firm issued an outperform rating and a $60.00 price objective on the biopharmaceutical companys stock. A number of other equities research analysts also recently issued reports on PFE. Morgan Stanley increased their price objective []